Macquarie Group’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,718
| Closed | -$316K | – | 2209 |
|
|
2024
Q1 | $316K | Hold |
14,718
| – | – | ﹤0.01% | 1484 |
|
|
2023
Q4 | $54K | Hold |
14,718
| – | – | ﹤0.01% | 1586 |
|
|
2023
Q3 | $57K | Buy |
+14,718
| New | +$57K | ﹤0.01% | 1583 |
|
|
2023
Q2 | – | Sell |
-14,718
| Closed | -$44K | – | 1747 |
|
|
2023
Q1 | $44K | Hold |
14,718
| – | – | ﹤0.01% | 1636 |
|
|
2022
Q4 | $74K | Hold |
14,718
| – | – | ﹤0.01% | 1655 |
|
|
2022
Q3 | $96K | Hold |
14,718
| – | – | ﹤0.01% | 1771 |
|
|
2022
Q2 | $107K | Hold |
14,718
| – | – | ﹤0.01% | 1857 |
|
|
2022
Q1 | $217 | Hold |
14,718
| – | – | ﹤0.01% | 1791 |
|
|
2021
Q4 | $706K | Hold |
14,718
| – | – | ﹤0.01% | 1615 |
|
|
2021
Q3 | $2.15M | Hold |
14,718
| – | – | ﹤0.01% | 1365 |
|
|
2021
Q2 | $1.7M | Hold |
14,718
| – | – | ﹤0.01% | 1461 |
|
|
2021
Q1 | $1.42M | Buy |
+14,718
| New | +$1.42M | ﹤0.01% | 1306 |
|